TME Pharma N.V. financials at a glance

The revenue of TME Pharma N.V. is reported as 3.0E-5 billion Euro in the fiscal year 2023. The earnings were -12.86 Euro per share in 2023, which was 0 higher than 2022. And about -0.00972 billion Euro are reported as free cash flow in the financials of TME Pharma N.V. 2023. No dividends were paid to the shareholders of the TME Pharma N.V. stock ENXTPA:ALTME in the financial year 2023.